Immunotherapy Weekly back issues from December 2001:
Calcium Mobilization Induces Th2-Type Dendritic Cell Activity.(Brief Article)
Dec 05, 2001 ... 2001 DEC 5 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Dendritic cells mobilized with calcium may be beneficial for patients with some autoimmune disorders, researchers in the United States say. "Mature dendritic cells (DCs), in addition to providing ...
Immune System Discovery May Lead To Preventive Therapy For Diabetes.(Brief Article)
Dec 05, 2001 ... 2001 DEC 5 - (NewsRx.com & NewsRx.net) -- By manipulating a cell that controls the immune system's response to infections, researchers at Dana-Farber Cancer Institute and their colleague have prevented the onset of diabetes in mice predisposed to the disease. The finding one day ...
Adalimumab Supplements Methotrexate Therapy.(Brief Article)
Dec 05, 2001 ... 2001 DEC 5 - (NewsRx.com & NewsRx.net) -- People with rheumatoid arthritis who are already taking methotrexate may have further improvement in arthritis control with the addition of a new injectable treatment called adalimumab, according to research presented at the American College of ...
Researchers Identify Enzyme Responsible For Genetic Diversity.(Brief Article)
Dec 05, 2001 ... 2001 DEC 5 - (NewsRx.com & NewsRx.net) -- Simultaneous reports by two teams at the Scripps Research Institute (TSRI), led by Professor Paul Russell, PhD, and Associate Professor Clare H. McGowan, PhD, identify the resolvase enzyme that may be responsible for generating genetic diversity ...
Corticosteroids Appropriate For Hepatitis C-Autoimmune Hepatitis Overlap.(Brief Article)
Dec 05, 2001 ... 2001 DEC 5 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Physicians who treat cases of hepatitis C-autoimmune hepatitis overlap can use steroids, but they should not expect viral eradication, a new study indicates. Mt. Sinai Medical Center investigator ...
Infliximab Demonstrates Broad Range Of Immune-Mediated Disorders.(Brief Article)
Dec 05, 2001 ... 2001 DEC 5 - (NewsRx.com & NewsRx.net) -- A number of investigational initial studies on the investigational use of Remicade (infliximab) in an wide array of immune-mediated inflammatory disorders was presented at the annual meeting of the American College of Rheumatology (ACR) in San ...
Stem Cell Transplantation Effective.(Brief Article)
Dec 05, 2001 ... 2001 DEC 5 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Australia say that hematopoietic stem cell transplantation may be an effective method for treating rheumatoid arthritis. "Trials of high dose immunosuppression and peripheral blood ...
Cytokines Join Race, Viral Genotype For Predicting Interferon Resistance.(Brief Article)
Dec 05, 2001 ... 2001 DEC 5 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Scientists are now calling cytokines a significant determinant for whether or not a patient with chronic hepatitis C responds to interferon. Cytokines, cellular proteins that regulate a variety ...
Air Cleaners Help Asthmatics Exercise Indoors.(Brief Article)
Dec 05, 2001 ... 2001 DEC 5 - (NewsRx.com & NewsRx.net) -- Clean Air Delivery Rate (CADR)-certified air cleaners are a must for allergy sufferers as the cold air extends its reach this winter season and exercise programs begin moving indoors. Cold air can be an asthma trigger, plus cold air is, ...
Phase II Study Shows Patients Respond To Etanercept.(Brief Article)
Dec 05, 2001 ... 2001 DEC 5 - (NewsRx.com & NewsRx.net) -- Data from a Phase 2 clinical study of ENBREL (etanercept) in ankylosing spondylitis was presented this week at the 65th Annual Scientific Meeting of the American College of Rheumatology. This study, conducted by Dr. John Davis and ...
BioVex Names Group Leader of Immunology.(Brief Article)
Dec 05, 2001 ... 2001 DEC 5 - (NewsRx.com & NewsRx.net) -- BioVex, Ltd. has appointed Dr. Philip Reay to the position of group leader, immunology. Prior to joining BioVex, Reay was a senior research fellow in the Nuffield Department of Clinical Medicine and the Molecular Immunology Group at the University ...
Costimulation Blockers Show Promise In Trials.(Brief Article)
Dec 05, 2001 ... 2001 DEC 5 - (NewsRx.com & NewsRx.net) -- Two investigational therapies show promise in treating rheumatoid arthritis, according to research presented at the American College of Rheumatology Annual Scientific Meeting in San Francisco, California. The compounds - CTLA4Ig and ...
Methotrexate, Anakinra Combination Alternative For Disease Control.(Brief Article)
Dec 05, 2001 ... 2001 DEC 5 - (NewsRx.com & NewsRx.net) -- People with rheumatoid arthritis who take methotrexate but continue to have active arthritis may have further improvement in arthritis control with the addition of a new injectable treatment called anakinra, according to research presented at the ...
RTI Inks Deal With MSD For New Spinal Allograft.(Regeneration Technologies Inc)(Medtronic Sofamor Danek Manufacturing)(Brief Article)
Dec 05, 2001 ... 2001 DEC 5 - (NewsRx.com & NewsRx.net) -- Regeneration Technologies, Inc., (RTI) has signed an agreement with Medtronic Sofamor Danek (MSD) for the distribution of a new allograft. The terms of the new agreement call for an increased share of revenues for RTI. MSD, which has ...
Biomira Receives Patent Protection For Its Idiotypic Vaccines.(Brief Article)
Dec 05, 2001 ... 2001 DEC 5 - (NewsRx.com & NewsRx.net) -- Biomira, Inc. (BIOM) announced that its subsidiary, Biomira USA, Inc., was issued a second patent from the U.S. Patent and Trademark Office for composition of matter used in Biomira's cancer vaccine program. The issued patent, number ...
Using A Patient's Own Bone Marrow Cells Can Help Ailing Heart.(Brief Article)
Dec 05, 2001 ... 2001 DEC 5 - (NewsRx.com & NewsRx.net) -- In the first study of its kind, researchers have used a person's own bone marrow cells to improve blood flow in otherwise untreatable coronary arteries, according to research presented at the American Heart Association's Scientific Sessions 2001 ...
Phase II Clinical Trial With MVA-HPV-IL2 Immunotherapy Initiated.(Brief Article)
Dec 05, 2001 ... 2001 DEC 5 - (NewsRx.com & NewsRx.net) -- Transgene (TRGNY) announced the initiation of a Phase II clinical trial of its immunotherapeutic MVA-HPV-IL2 product candidate for the treatment of cervical cancer. The trial will be conducted in Mexico and will include up to 57 women ...
New Treatment Available For Patients With Heart/Lung Comorbidities.(Brief Article)
Dec 05, 2001 ... 2001 DEC 5 - (NewsRx.com & NewsRx.net) -- Treprostinil, a structural analogue of naturally occurring prostacyclin, has been shown to be safe and effective in the treatment of patients with pulmonary hypertension associated with various forms of connective tissue disease, according to ...
New Therapies Proving Effective For Millions.(Brief Article)
Dec 05, 2001 ... 2001 DEC 5 - (NewsRx.com & NewsRx.net) -- Eczema, a chronic skin disease that causes itching and inflammation and resulting redness, swelling, cracking, weeping, and scaling, affects 15 million Americans, many of them children. Speaking October 17, 2001, at the American Academy ...
Study Indicates Sweating May Help Fight Infection.(Brief Article)
Dec 05, 2001 ... 2001 DEC 5 - (NewsRx.com & NewsRx.net) -- No one likes to sweat, but we may need to change our attitude as new research suggests sweating can actually help fight infection. In the December 2001 issue of Nature Immunology scientists show that human sweat contains an antimicrobial ...
AltaRex Announces Results for Third Quarter 2001.(Brief Article)
Dec 05, 2001 ... 2001 DEC 5 - (NewsRx.com & NewsRx.net) -- AltaRex Corp. (AXO.TO, ALXFF.OTC), a developer of foreign antibodies that activate the immune system to treat cancer, announced its financial results for the third quarter ended September 30, 2001. All dollars reported are Canadian. ...
AtheroGenics Reports Third Quarter Results.(Brief Article)
Dec 05, 2001 ... 2001 DEC 5 - (NewsRx.com & NewsRx.net) -- AtheroGenics, Inc., (AGIX) reported financial results for the three and nine months ended September 30, 2001, and announced that a new compound for the prevention of solid organ transplant rejection has been nominated into clinical development. ...
Blood Inflammatory Marker May Provide Risk Information.(Brief Article)
Dec 05, 2001 ... 2001 DEC 5 - (NewsRx.com & NewsRx.net) -- Blood levels of C-reactive protein (CRP) may provide information about the risk of ischemic heart disease (IHD) in middle-age men, according to an article in the November 12, 2001, issue of the Archives of Internal Medicine. Matteo ...
Vaccine Progresses to Phase II Human Trials.(Brief Article)
Dec 05, 2001 ... 2001 DEC 5 - (NewsRx.com & NewsRx.net) -- Antex Biologics, Inc. (ANX) has completed laboratory analyses of its Phase 1B clinical trial of Helivax, the Company's oral vaccine intended to prevent and treat gastrointestinal infections and disease caused by Helicobacter pylori. The ...
Interferon (alpha)-Producing Cell Identified As Fast Response Component.(Brief Article)
Dec 05, 2001 ... 2001 DEC 5 - (NewsRx.com & NewsRx.net) -- How do our bodies know when a virus is lurking about? In the December 2001 issue of Nature Immunology, G. Trinchieri and colleagues at the Schering-Plough Research Institute in Dardilly, France, report the identity in mice of a ...
Researchers Find One Type Of T Cell Acts Strangely.(Brief Article)
Dec 05, 2001 ... 2001 DEC 5 - (NewsRx.com & NewsRx.net) -- Ischemia, or an interruption in blood flow to tissue, greatly decreases the success of transplanted kidneys. There's no specific treatment, partly because physicians don't know exactly how the injury occurs. But now, a new study shows ...
Lactoferrin Fights Off Cell-Associated Hepatitis.(Brief Article)
Dec 05, 2001 ... 2001 DEC 5 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - A recombinant form of the human breast milk protein lactoferrin can combat phagocytic liver cells sensitized to produce hepatitis. Thus far, lactoferrin inhibition of sensitized Kupffer cells has ...
Levels Of Antibodies At Liver Stage May Predict Resistance To Disease.(Brief Article)
Dec 05, 2001 ... 2001 DEC 5 - (NewsRx.com & NewsRx.net) -- High levels of antibodies against the liver stage of the malaria parasite appear to predict resistance to the disease say researchers from Brown University and the Seattle Biomedical Research Institute. These findings could eventually ...
Need For Knee Replacement Delayed, Prevented Using Viscosupplementation.(Brief Article)
Dec 05, 2001 ... 2001 DEC 5 - (NewsRx.com & NewsRx.net) -- Dr. David D. Waddell, a Shreveport orthopedic surgeon, presenting at the annual meeting of the American College of Rheumatology discussed results of two ground-breaking research studies he has completed about the effectiveness of knee injection ...
InterMune Expands Strategic Partnership With Boehringer Ingelheim.(Brief Article)
Dec 05, 2001 ... 2001 DEC 5 - (NewsRx.com & NewsRx.net) -- InterMune, Inc., (ITMN) has expanded its international strategic partnership with Boehringer Ingelheim International GmbH to include the development and commercialization of interferon (gamma)-1b for the treatment of ovarian cancer. ...
New Drugs Hold Promise For Safety, Effectiveness In Treatment.(Brief Article)
Dec 05, 2001 ... 2001 DEC 5 - (NewsRx.com & NewsRx.net) -- A multicenter, international pilot study of two new drugs to treat patients with rheumatoid arthritis has found the drugs to be safe and effective in treating the disease. Larry Moreland, MD, professor of medicine at the University of ...
LJP 394 Reduces Renal Complications.(La Jolla Pharmaceutical Co.)(lupus research)(Brief Article)
Dec 05, 2001 ... 2001 DEC 5 - (NewsRx.com & NewsRx.net) -- La Jolla Pharmaceutical Company presented additional data from an earlier Phase II/III clinical trial of its clinical candidate for systemic lupus erythematosus (lupus), LJP 394, at the 2001 World Congress of Nephrology. Data from the ...
Scientists discover Why Autoimmune Disease Affects Nervous System.(Brief Article)
Dec 05, 2001 ... 2001 DEC 5 - (NewsRx.com & NewsRx.net) -- Researchers think they now know why systemic lupus erythematosus (lupus) attacks the nervous system, according to a new report in Nature Medicine. Lupus is a disorder of the immune system in which the body produces antibodies that attack ...
MedImmune Licenses Cancer Target From Purdue Research Foundation.(Brief Article)
Dec 05, 2001 ... 2001 DEC 5 - (NewsRx.com & NewsRx.net) -- MedImmune, Inc., has licensed worldwide rights to EphA2 technology from Purdue Research Foundation. MedImmune will be responsible for developing, manufacturing, and commercializing therapeutics that target EphA2. These products will ...
HIV Specific T Cells May Not Be Crucial For Early Protection.(Brief Article)
Dec 12, 2001 ... 2001 DEC 12 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States and Europe say that immune protection against acute HIV infection does not seem to be exclusively mediated by HIV specific T cells. "Human immunodeficiency virus ...
Signals From Nervous System Influence Immune System.(Brief Article)
Dec 12, 2001 ... 2001 DEC 12 - (NewsRx.com & NewsRx.net) -- In a discovery that demonstrates a clear link between the mind and body at the molecular level, scientists have shown that a chemical signal that normally allows nerve cells to communicate with each other - to alter sleep cycles, for example - can ...
Specialist Do Better Job Of Managing Disease.(Brief Article)
Dec 12, 2001 ... 2001 DEC 12 - (NewsRx.com & NewsRx.net) -- Patients with asthma are less likely to cancel activities or miss work or be hospitalized or visit an emergency department for asthma if they are treated by certain specialists or a generalist physician experienced at treating asthma, according to ...
Scientist Identify Gene's Role In Causing Infections.(Brief Article)
Dec 12, 2001 ... 2001 DEC 12 - (NewsRx.com & NewsRx.net) -- Cystic fibrosis (CF) is a fatal lung disease caused by an altered gene, but how the gene affects cells is not completely understood. Now, researchers have new evidence suggesting the gene can change the internal chemistry of some lung cells, ...
New Tools Help Improve Rheumatic Practice.(Brief Article)
Dec 12, 2001 ... 2001 DEC 12 - (NewsRx.com & NewsRx.net) -- by Michelle Marble, senior medical writer - Advances in technology typically result in advances in diagnostics and therapeutics, according to several presenters at clinical symposia at the 65th Annual Scientific Meeting of the American College of ...
Researchers Define Precursors To Cells That Control Immune Response.(Brief Article)
Dec 12, 2001 ... 2001 DEC 12 - (NewsRx.com & NewsRx.net) -- University of Pittsburgh researchers have identified the precursors of epidermal Langerhan cells (LCs), cells that reside in the skin and play a key role in the initiation and regulation of the immune response throughout the body. Researchers may ...
Lupus Brain Damage Pathway Identified Through Molecular Mechanism.(Brief Article)
Dec 12, 2001 ... 2001 DEC 12 - (NewsRx.com & NewsRx.net) -- Scientists studying systemic lupus erythematosus (SLE), a chronic, inflammatory, autoimmune disease whose symptoms can include neurological damage, have discovered a possible molecular mechanism for brain dysfunction in some people with the ...
Smoker Siblings Of COPD Patients At Significant Risk.(chronic obstructive pulmonary disease )(Brief Article)
Dec 12, 2001 ... 2001 DEC 12 - (NewsRx.com & NewsRx.net) -- Smoker siblings of patients with severe chronic obstructive pulmonary disease (COPD) have a significant risk of airflow obstruction, according to an article in the second issue for October 2001 of the American Thoracic Society's (ATS) ...
Nanoparticles Pose Greater Cardiopulmonary Risk Than Thought.(Brief Article)
Dec 12, 2001 ... 2001 DEC 12 - (NewsRx.com & NewsRx.net) -- Tiny airborne particles too small to see are more plentiful and may pose a greater health hazard than previously thought, says an Oak Ridge National Laboratory researcher studying airborne particles in the Great Smoky Mountains and beyond. ...
FDA Approves Onset-Of-Action Label Change For Budesonide.(Brief Article)
Dec 12, 2001 ... 2001 DEC 12 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration has approved revised labeling describing an onset of action within 10 hours for its allergic rhinitis medication, Rhinocort Aqua (budesonide) nasal spray, according to AstraZeneca LP. The labeling change was ...
Steroid Nasal Spray Better For Season Allergies Than Antihistamines.(Brief Article)
Dec 12, 2001 ... 2001 DEC 12 - (NewsRx.com & NewsRx.net) -- Steroid nasal sprays reduce allergic inflammation and are more effective than antihistamines in treating seasonal allergies on an as-needed basis, according to an article in the November 26, 2001, issue of the Archives of Internal Medicine. ...
Research Takes Mind-Over-Matter Approach To Bowel Disorder.(Brief Article)
Dec 12, 2001 ... 2001 DEC 12 - (NewsRx.com & NewsRx.net) -- Dawn Barsky always suspected that her bowel problems were triggered by stress. Now she knows how to ease her symptoms by changing the way she thinks and acts when faced with daily challenges. "What it boils down to is, we have certain ...
Scientists Identify Role Of Immune Response In Disease Pathology.(Brief Article)
Dec 12, 2001 ... 2001 DEC 12 - (NewsRx.com & NewsRx.net) -- Utrecht researchers have determined the role played by brain cells from the immune system that are located close to dying memory cells. The research will help determine the causes of Alzheimer disease. In patients with Alzheimer ...
FDA Approves New Class Of Therapy For Rheumatoid Arthritis.(Brief Article)
Dec 12, 2001 ... 2001 DEC 12 - (NewsRx.com & NewsRx.net) -- The first in a new class of therapy for rheumatoid arthritis has won federal approval although studies show Kineret promises just modest effectiveness. The U.S. Food and Drug Administration (FDA) said the new drug should be reserved for ...
Ethnic Minorities More Likely To Be Sensitive To Indoor Allergens.(Brief Article)
Dec 12, 2001 ... 2001 DEC 12 - (NewsRx.com & NewsRx.net) -- For the first time, significant racial differences in allergic sensitivity to cockroach, dust mite, and mold have been found in the general childhood population of the United States. These differences have previously been documented in local ...
Pilot Gets More Funding From Quintiles For Novel Medical Food.(Brief Article)
Dec 12, 2001 ... 2001 DEC 12 - (NewsRx.com & NewsRx.net) -- As part of the commercialization alliance announced in June between Pilot Therapeutics, Inc., (ILRG.OB) and Quintiles Transnational Corp. (QTRN) for Airozin, Pilot's novel medical food for asthma, Pilot has achieved the second milestone ...
University Of Cincinnati Scientists Identify New Gene.(Brief Article)
Dec 12, 2001 ... 2001 DEC 12 - (NewsRx.com & NewsRx.net) -- A team of researchers led by Anil Menon, PhD, associate professor of molecular genetics, University of Cincinnati (UC) College of Medicine, Ohio, has identified the gene for Aquaporin 5, a mercury-sensitive water channel found in certain cells of ...
Data Support Potential Of LymphoStat-B Therapy.(Brief Article)
Dec 12, 2001 ... 2001 DEC 12 - (NewsRx.com & NewsRx.net) -- Human Genome Sciences, Inc., announced that data presented at the American College of Rheumatology Annual Meeting in San Francisco, California, support the potential of LymphoStat-B, a human monoclonal antibody targeting BLyS (B lymphocyte ...
Valdecoxib Effective In Treating OA And RA With Fewer Gastrointestinal Side Effects.(Brief Article)
Dec 12, 2001 ... 2001 DEC 12 - (NewsRx.com & NewsRx.net) -- Results from two Phase III clinical studies of the potent investigational COX-2-specific inhibitor valdecoxib showed that it demonstrated similar efficacy to the conventional non-steroidal anti-inflammatory drug (NSAID) naproxen when compared with ...
Thalidomide Tested As Potential COX-2/Cancer Inhibitor.(Brief Article)
Dec 12, 2001 ... 2001 DEC 12 - (NewsRx.com & NewsRx.net) -- Celgene Corp. (CELG) and the Joan and Sanford I. Weill Medical College of Cornell University announced November 20, 2001, that data from an in vitro study determined that thalidomide and IMiDs (immunomodulatory drugs) inhibited COX-2 ...
Lack Of Known Cause, Basic Knowledge Pose Barrier To Diagnosis.(Brief Article)
Dec 12, 2001 ... 2001 DEC 12 - (NewsRx.com & NewsRx.net) -- Thirteen years after a group of scientists coined the term chronic fatigue syndrome (CFS) to describe a mysterious medical condition, many medical professionals are acknowledging it as a seriously disabling condition in need of treatment, ...
ImmunoGen Reports First-Quarter Results.(Brief Article)
Dec 12, 2001 ... 2001 DEC 12 - (NewsRx.com & NewsRx.net) -- ImmunoGen, Inc., (IMGN) has announced financial results for the first quarter ended September 30, 2001. For the three-month period, the company reported a net loss of $1,593,000, or $0.04 per share, compared with a net loss before the cumulative ...
Lorantis Closes 16.2 Million Pounds Sterling Second Round Financing.(Brief Article)
Dec 12, 2001 ... 2001 DEC 12 - (NewsRx.com & NewsRx.net) -- Lorantis, Ltd., an emerging immunology drug discovery company, has announced the final closing of a 16.2 million pounds sterling (US$23.5) second round financing, having received a further 4.7 million pounds. New investors The Wellcome Trust and ...
$1.1 Million NIH Grant Funds Research Into Asthma, Lupus.(Brief Article)
Dec 12, 2001 ... 2001 DEC 12 - (NewsRx.com & NewsRx.net) -- University at Buffalo researchers have received a five-year, $1.1 million grant from the U.S. National Institutes of Health to assess environmental pollutants and their relationship to the prevalence of autoimmune disease, particularly lupus, and ...
Researchers Find Evidence Our Skin Makes Its Own Antibiotics.(Brief Article)
Dec 12, 2001 ... 2001 DEC 12 - (NewsRx.com & NewsRx.net) -- Natural antibiotics may protect our skin from bacteria, according to a new study reported in Nature. Mice lacking protein fragments called cathelicidins are much more susceptible to infection of 'flesh-eating' Streptococcus than are ...
Yeast Genes May Hold Key To Radiation Protection, Cancer Survival.(Brief Article)
Dec 12, 2001 ... 2001 DEC 12 - (NewsRx.com & NewsRx.net) -- What protects us from radiation? Some answers are found in more than 100 yeast genes A novel search of 3760 "nonessential" yeast genes has revealed 107 new genes that may determine how we resist, or are hurt by, radiation and whether we ...
Ultraviolet B Exposure Has No Bearing On Hepatitis B Vaccine Effectiveness.(Brief Article)
Dec 12, 2001 ... 2001 DEC 12 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Ultraviolet radiation exposure, known to suppress immune system response, does not affect the body's response to hepatitis B virus (HBV) vaccine. It does however, affect other avenues of immune ...
Sea Anemone Toxin Halts Experimental Disease.(Brief Article)
Dec 12, 2001 ... 2001 DEC 12 - (NewsRx.com & NewsRx.net) -- Sea anemones use venom to stun their prey, but one component of that venom halts - and may reverse - the paralysis seen in an experimental form of multiple sclerosis, according to a study by University of California at Irvine's College of Medicine ...
Researchers Discover Regulator Of Bone Density.(Brief Article)
Dec 12, 2001 ... 2001 DEC 12 - (NewsRx.com & NewsRx.net) -- Researchers tracking the cause of a rare genetic disorder that causes brittle bones have discovered a genetic "thermostat" that appears to control the accumulation of bone mass during growth. The findings could substantially increase ...
COX-2 Inhibitors May Slow Ligament Healing.(Brief Article)
Dec 12, 2001 ... 2001 DEC 12 - (NewsRx.com & NewsRx.net) -- A new class of nonaspirin pain medicine now widely prescribed for arthritis symptoms may impair ligament healing associated with sprains, according to laboratory findings at the University of North Carolina at Chapel Hill. The newer ...
5G1.1 Biological Therapy Looks Promising.
Dec 12, 2001 ... 2001 DEC 12 - (NewsRx.com & NewsRx.net) -- Alexion Pharmaceuticals, Inc., presented clinical safety, efficacy, and biological data from a Phase II trial of 5G1.1 in rheumatoid arthritis patients at the November 2001 meeting of the american College of Rheumatology in San Francisco, ...